The Food and Drug Administration granted approval for a second generic version of the abortion pill mifepristone, sparking outrage among anti-abortion conservatives, as it will likely increase the prevalence of medication abortions.
The FDA on Thursday approved the generic drug to be made by the telehealth abortion company Evita Solutions, according to a copy of the FDA approval letter obtained by the Washington Examiner.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.